
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services; 2 Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland; 3 Department of Community and Family Medicine, Dartmouth Medical School, Hanover, New Hampshire; 4 Department of Hygiene and Epidemiology, University of Athens Medical School, Athens, Greece; 5 Department of Epidemiology, Harvard School of Public Health; 6 Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; 7 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 8 Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China; 9 Reproductive Endocrine Research Laboratory, University of Southern California Keck School of Medicine, Los Angeles, California; and 10 Department of Cancer Biology, University of Massachusetts Medical Center, Worcester, Massachusetts
Requests for reprints: Rebecca Troisi, Dartmouth-Hitchcock Medical Center, Room 854, 7297 Rubin Building, One Medical Center Drive, Lebanon, NH 03756. Phone: 603-653-9024. E-mail: troisir{at}mail.nih.gov
Markedly lower breast cancer incidence rates in Asians than Caucasians are not explained by established adult risk factors. Migration studies suggest the importance of early-life exposures, including perhaps the in utero period. Concentrations of steroid hormones and insulin-like growth factors (IGF) were measured in umbilical cord sera from pregnancies in Shanghai, China (n = 121) and Boston, MA (n = 111). Pregnancy characteristics were ascertained by interview and medical records. Means and percent differences in hormone concentrations comparing Chinese with Caucasians and 95% confidence intervals were estimated from linear regression models. Cord concentrations of androstenedione (91.9%), testosterone (257%), estriol (48.6%), and IGF binding protein-3 (21.1%) were significantly higher in the Chinese than U.S. samples, and cord prolactin was lower (–14.9%). Cord estradiol and IGF-I concentrations did not differ by race/ethnicity. With adjustment for gestational length, maternal age, pre-pregnancy weight, and weight gain, androstenedione (60.5%), testosterone (185%), and IGF binding protein-3 (40.4%) remained significantly higher in the Chinese, whereas the higher estriol and lower prolactin concentrations were attenuated. In addition, estradiol levels became lower in the Chinese (–29.8%) but did not reach statistical significance. Results were generally similar when restricted to first full-term pregnancies, with reduced estradiol concentrations in the Chinese reaching statistical significance after adjustment. These data are consistent with the hypothesis that elevated prenatal androgen exposure could mediate reductions in breast cancer risk. The meaning of the change in findings for estrogens after controlling for factors related to the pregnancy is unclear with regard to explaining international breast cancer differences. (Cancer Epidemiol Biomarkers Prev 2008;17(1):224–31)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |